scientific article; zbMATH DE number 7513920
From MaRDI portal
Publication:5072154
DOI10.5705/SS.202020.0412MaRDI QIDQ5072154FDOQ5072154
Authors: Kwok Pui Choi, Tze Leung Lai, Weng Kee Wong, Xin Thomson Tong
Publication date: 25 April 2022
Title of this publication is not available (Why is that?)
Recommendations
- Adaptive optimal designs for dose-finding studies based on sigmoid \(E_{\max}\) models
- Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint
- Optimal parametric design with applications to pharmacokinetic and pharmacodynamic trials
- Optimal adaptive randomized designs for clinical trials
- scientific article; zbMATH DE number 7703241
- Some optimal adaptive designs in clinical trials
- Adaptive designs for dose-finding based on efficacy-toxicity response
adaptive group sequential designscompound optimality criterion for toxicity and efficacylocally D-optimal and c-optimal designs
Cites Work
- A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Bootstrap procedures under some non-i.i.d. models
- The Equivalence of Two Extremum Problems
- Optimum experimental designs, with SAS
- Locally Optimal Designs for Estimating Parameters
- Optimal Design of Experiments
- Asymptotically efficient adaptive allocation rules
- Some aspects of the sequential design of experiments
- Finite-time analysis of the multiarmed bandit problem
- On the Equivalence of Constrained and Compound Optimal Designs
- Consistency of continual reassessment method under model misspecification
- Sequential experimentation in clinical trials. Design and analysis
- Adaptive treatment allocation and the multi-armed bandit problem
- Stochastic approximation and modern model-based designs for dose-finding clinical trials
- Continual reassessment and related dose-finding designs
- Optimal designs and limiting optimal designs for a trinomial response
- Approximate dynamic programming and its applications to the design of Phase I cancer trials
- Optimal Bayesian-feasible dose escalation for cancer phase I trials
- The Equivalence of Constrained and Weighted Designs in Multiple Objective Design Problems
- Bayesian models and decision algorithms for complex early phase clinical trials
- Sequential Generalized Likelihood Ratios and Adaptive Treatment Allocation for Optimal Sequential Selection
- Particle swarm optimisation. Classical and quantum perspectives. With CD-ROM.
Cited In (3)
This page was built for publication:
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5072154)